» Articles » PMID: 25331326

International Patterns and Trends in Testicular Cancer Incidence, Overall and by Histologic Subtype, 1973-2007

Overview
Journal Andrology
Date 2014 Oct 22
PMID 25331326
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Incidence rates of testicular cancer in Northern European and North American countries have been widely reported, whereas rates in other populations, such as Eastern Europe, Central/South America, Asia, and Africa, have been less frequently evaluated. We examined testicular cancer incidence rates overall and by histologic type by calendar time and birth cohort for selected global populations 1973-2007. Age-standardized incidence rates over succeeding 5-year periods were calculated from volumes 4-9 of Cancer Incidence in Five Continents electronic database (CI5plus) and the newly released CI5X (volume 10) database. Annual percent change over the 35-year period was calculated using weighted least squares regression. Age-period-cohort analyses were performed and observed rates and fitted rate ratios presented by birth cohort. Incidence rates of testicular cancer increased between 1973-1977 and 2003-2007 in most populations evaluated worldwide. Of note, incidence rates in Eastern European countries rose rapidly and approached rates in Northern European countries. Rates in Central and South America also increased and are now intermediate to the high rates among men of European ancestry and low rates among men of Asian or African descent. Some heterogeneity in the trends in seminoma and nonseminoma were observed in Denmark, the United Kingdom, and among US whites, particularly in recent generations, with rapid and uniform increases in the incidence of both histologic types in Slovakia. Reasons for the rising incidence rates among European and American populations remain unexplained; however, changing distributions in the prevalence of risk factors for testicular cancer cannot be ruled out.

Citing Articles

Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide study.

Lindahl N, Lauritsen J, Wagner T, Daugaard G, Bandak M Acta Oncol. 2025; 64:191-199.

PMID: 39886914 PMC: 11811535. DOI: 10.2340/1651-226X.2025.42281.


Trends in the global, regional, and national burden of testicular cancer from 1990 to 2019: an observational study with 30-year global data.

Zhou X, Zhang Z, Ruan C, Wu Y, Zeng B, Su X Int J Surg. 2024; 110(8):4633-4647.

PMID: 38759694 PMC: 11325982. DOI: 10.1097/JS9.0000000000001603.


Advancing GCT Management: A Review of miR-371a-3p and Other miRNAs in Comparison to Traditional Serum Tumor Markers.

Seales C, Puri D, Yodkhunnatham N, Pandit K, Yuen K, Murray S Cancers (Basel). 2024; 16(7).

PMID: 38611057 PMC: 11010994. DOI: 10.3390/cancers16071379.


New insights on testicular cancer prevalence with novel diagnostic biomarkers and therapeutic approaches.

Sadek K, AbdEllatief H, Mahmoud S, Alexiou A, Papadakis M, Al-Hajeili M Cancer Rep (Hoboken). 2024; 7(3):e2052.

PMID: 38507271 PMC: 10953835. DOI: 10.1002/cnr2.2052.


The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan.

Suzuki S, Nagumo Y, Kandori S, Kojo K, Nitta S, Chihara I Int J Clin Oncol. 2024; 29(3):318-324.

PMID: 38265529 DOI: 10.1007/s10147-023-02457-0.


References
1.
Ekbom A, Richiardi L, Akre O, Montgomery S, Sparen P . Age at immigration and duration of stay in relation to risk for testicular cancer among Finnish immigrants in Sweden. J Natl Cancer Inst. 2003; 95(16):1238-40. DOI: 10.1093/jnci/djg012. View

2.
Purdue M, Devesa S, Sigurdson A, McGlynn K . International patterns and trends in testis cancer incidence. Int J Cancer. 2005; 115(5):822-7. DOI: 10.1002/ijc.20931. View

3.
Clayton D, Schifflers E . Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med. 1987; 6(4):469-81. DOI: 10.1002/sim.4780060406. View

4.
Clayton D, Schifflers E . Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med. 1987; 6(4):449-67. DOI: 10.1002/sim.4780060405. View

5.
Znaor A, Lortet-Tieulent J, Jemal A, Bray F . International variations and trends in testicular cancer incidence and mortality. Eur Urol. 2013; 65(6):1095-106. DOI: 10.1016/j.eururo.2013.11.004. View